Japan Non-alcoholic Steatohepatitis Market (2025-2031) | Value, Growth, Companies, Outlook, Trends, Analysis, Industry, Share, Segmentation, Forecast, Competitive Landscape, Size & Revenue

Name: Japan Non-alcoholic Steatohepatitis Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib and Cenicriviroc, Obeticholic Acid, Others), By Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), By Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), By End User (Hospitals, Clinics, Homecare settings) And Competitive Landscape

Product Code: ETC7743730	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

Japan Non-alcoholic Steatohepatitis Market Outlook
Market Size of Japan Non-alcoholic Steatohepatitis Market, 2024
Forecast of Japan Non-alcoholic Steatohepatitis Market, 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Revenues & Volume for the Period 2021- 2031
Japan Non-alcoholic Steatohepatitis Market Trend Evolution
Japan Non-alcoholic Steatohepatitis Market Drivers and Challenges
Japan Non-alcoholic Steatohepatitis Price Trends
Japan Non-alcoholic Steatohepatitis Porter's Five Forces
Japan Non-alcoholic Steatohepatitis Industry Life Cycle
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Drug Type for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Vitamin E and Pioglitazone for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Ocaliva for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Elafibranor for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Selonsertib and Cenicriviroc for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Obeticholic Acid for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Sales Channel for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Online Providers for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Disease Cause for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Hypertension for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Heart Disease for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By High Blood Lipid for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Type 2 Diabetes for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Obesity for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By End User for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of Japan Non-alcoholic Steatohepatitis Market Revenues & Volume By Homecare settings for the Period 2021- 2031
Japan Non-alcoholic Steatohepatitis Import Export Trade Statistics
Market Opportunity Assessment By Drug Type
Market Opportunity Assessment By Sales Channel
Market Opportunity Assessment By Disease Cause
Market Opportunity Assessment By End User
Japan Non-alcoholic Steatohepatitis Top Companies Market Share
Japan Non-alcoholic Steatohepatitis Competitive Benchmarking By Technical and Operational Parameters
Japan Non-alcoholic Steatohepatitis Company Profiles
Japan Non-alcoholic Steatohepatitis Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Japan Non-alcoholic Steatohepatitis Market Overview

3.1 Japan Country Macro Economic Indicators

3.2 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F

3.3 Japan Non-alcoholic Steatohepatitis Market - Industry Life Cycle

3.4 Japan Non-alcoholic Steatohepatitis Market - Porter's Five Forces

3.5 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

3.7 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F

3.8 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F

4 Japan Non-alcoholic Steatohepatitis Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Japan

4.2.2 Growing awareness about the risks associated with NASH

4.2.3 Technological advancements in diagnostics and treatment options for NASH

4.3 Market Restraints

4.3.1 High cost of NASH treatments

4.3.2 Limited availability of effective therapies for NASH in Japan

4.3.3 Stringent regulatory requirements for approval of NASH drugs in the Japanese market

5 Japan Non-alcoholic Steatohepatitis Market Trends

6 Japan Non-alcoholic Steatohepatitis Market, By Types

6.1 Japan Non-alcoholic Steatohepatitis Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F

6.1.5 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F

6.1.6 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F

6.1.7 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F

6.1.8 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F

6.2 Japan Non-alcoholic Steatohepatitis Market, By Sales Channel

6.2.1 Overview and Analysis

6.2.2 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F

6.2.4 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3 Japan Non-alcoholic Steatohepatitis Market, By Disease Cause

6.3.1 Overview and Analysis

6.3.2 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F

6.3.3 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F

6.3.4 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F

6.3.5 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F

6.3.6 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F

6.4 Japan Non-alcoholic Steatohepatitis Market, By End User

6.4.1 Overview and Analysis

6.4.2 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Japan Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F

7 Japan Non-alcoholic Steatohepatitis Market Import-Export Trade Statistics

7.1 Japan Non-alcoholic Steatohepatitis Market Export to Major Countries

7.2 Japan Non-alcoholic Steatohepatitis Market Imports from Major Countries

8 Japan Non-alcoholic Steatohepatitis Market Key Performance Indicators

8.1 Number of NASH diagnoses in Japan

8.2 Adoption rate of advanced diagnostic technologies for NASH

8.3 Patient adherence to NASH treatment regimens

8.4 Average time to market for new NASH therapies in Japan

8.5 Rate of improvement in liver health markers among NASH patients in Japan

9 Japan Non-alcoholic Steatohepatitis Market - Opportunity Assessment

9.1 Japan Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Japan Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

9.3 Japan Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F

9.4 Japan Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F

10 Japan Non-alcoholic Steatohepatitis Market - Competitive Landscape

10.1 Japan Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024

10.2 Japan Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Non-Alcoholic Steatohepatitis Market

Europe Non-Alcoholic Steatohepatitis Market

Global Non-alcoholic Steatohepatitis Market

Guyana Non-alcoholic Steatohepatitis Market

Haiti Non-alcoholic Steatohepatitis Market

Honduras Non-alcoholic Steatohepatitis Market

Hong Kong Non-alcoholic Steatohepatitis Market

Iceland Non-alcoholic Steatohepatitis Market

Middle East Non-Alcoholic Steatohepatitis Market

North America Non-Alcoholic Steatohepatitis Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here